Upcoming Webinar

How gut microbiota influence food intolerance and liver cancer risk

Thursday, August 26th, 2021

Time: 8 p.m. (Cairo) / 10 p.m. (Dubai) / 9 p.m. (Amman) / 8 p.m. (Vienna)

*Register now

*All webinar attendees receive a certificate of attendance! The names for the certificates are taken from the registration data!
For this reason, please register with your full name (no Arabic characters)!

Speakers Overview

 

Prof. Robin Spiller

UK

Prof. Mohamed El Kassas

EGYPT

 

Dr. Mohamed Alboraie

EGYPT

 

Prof. Robin Spiller (UK)

Biography

Professor Robin Spiller is professor of Gastroenterology in the Nottingham Digestive Diseases Centre at the University of Nottingham. Past editor of Gut (2003-2009) and member of the Board of the Rome Foundation (2000-2015). He twice edited the British Society of Gastroenterology (BSG) Guidelines for the management of IBS and is author/co-author of more than 388 scientific reviews and original publications. Current studies include an EME funded multicentre trial treatment of irritable bowel syndrome with diarrhoea using titrated Ondansetron (TRITON), RECLAIM an MRC funded study of colonic motility using MRI and high-resolution manometry and a Newton grant examining the effect of fibre of intestinal physiology in IBS.

 

Positions

  • 2000-current    Professor of Gastroenterology, University of Nottingham
  • 1998-2000    Reader in Gastroenterology, University of Nottingham 
  • 1988-1998    Consultant Physician, Nottingham University Hospitals NHS Trust
  • 1985-1988    Senior Registrar Central Middlesex Hospital 
  • 1984-1985    Eli Lily Travelling Fellowship to Mayo Clinic, Rochester, Minnesota, USA

Research interest

Prof. Spiller’s main research interest is the pathophysiology of Irritable Bowel Syndrome (IBS), particularly the role of infection, inflammation, diet and alterations in the microbiome as well as a long-standing collaboration with the Sir Peter Mansfield Imaging Centre pioneering the use of MRI to image the underlying mechanisms in functional bowel diseases and how the structure of food alters postprandial small and large intestinal volumes and motility.

Accolades

  • 2004    Barany Lecturer Swedish Gastroenterology meeting
  • 2009    Solly Marks Lecturer South African Gastroenterology meeting            
  • 2011    Sir Arthur Hurst Lecturer British Society of Gastroenterology
  • 2011    Charles Code Lecturer Mayo Clinic    
  • 2015    Life Time Achievement Award, European Society of Neurogastroenterology and Motility
  • 2016    Bardhan Lecture Sheffield Annual Gastroenterology meeting    
  • 2016    Rome lecturer Annual meeting of American Gastroenterological Association
  • 2017    Rome International Visiting Professor, Leuven University April    
  • 2018    Axon lecturer and Visiting Professor Leeds University February

Topic

Low FODMAP diet for Irritable Bowel Syndrome: evidence of efficacy and possible mechanisms

Prof. Mohamed El Kassas (EGYPT)

Biography

Professor El Kassas is associate professor and chief of Endemic Medicine and Hepato-Gastroenterology at the Faculty of Medicine, Helwan University, Egypt and president of the Egyptian Association for Research and Training in Hepato-Gastroenterology (EARTH). 
As founder and director of the Clinical Research Center, director of the Research Support Centre and chancellor of Scientific Research at Helwan University, he is also a member of the Specialized Scientific Council for Medical Research, ASRT. Moreover, he is currently appointed as the regional council member of International Association for Study of Liver (IASL) and member of The Global NASH Council. 
Prof. El Kassas has more than 80 articles published in indexed peer reviewed journals with a current H-index of 18. In addition to his interest in publications and peer review process, he is currently a reviewer in more than 40 hepatology and gastroenterology journals and is appointed as an editorial board member in many international journals. 
Prof. El Kassas had clinical and research training internships in Kyoto University (Japan), Pasteur Institute and l'hopital Tinon (France), Rotterdam University Hospital (Netherlands), University of Calgary (Canada) and Fresno Medical Center (California, USA). In the field of hepatology, Prof. El Kassas is experienced in various areas with focus on viral hepatitis, NAFLD and hepatocellular carcinoma. The professor is serving currently as a member of the Egyptian National Committee for Control of Viral Hepatitis in Egypt, and the supervisor of New Cairo Viral Hepatitis Treatment Center, collaborating with many international groups and organizations to eliminate hepatitis. 

 

Positions

  • Associate professor and head of the department of Endemic Medicine and Hepato-Gastroenterology, Faculty of Medicine, Helwan University, Cairo
  • Vice assistant manager of National Hepatology and tropical Medicine Research Institute, Cairo, Egypt
  • President of the Egyptian Association for Research & Training in Hepato-Gastroenterology (EARTH)

 

Research interest

The main research areas include hepatocellular carcinoma, viral hepatitis, infectious diseases and gastroenterology. Further skills comprise liver Immunology, biomarkers, virology, liver transplantation, Hepatitis (C), interferon, liver biopsy, viral load and Ribavirin.

 

Topic

The role of gut microbiota in liver cancer

 

Dr. Mohamed Alboraie (Egypt)

Biography

Dr. Alboraie is a graduate of Al-Azhar University in Cairo in 2002. He has got his master’s degree in internal medicine and gastroenterology in 2006, membership of the royal college of physicians of London (UK) in 2014, doctoral degree in internal medicine and gastroenterology from Al-Azhar university in 2015 and European Specialty Certificate in Gastroenterology and Hepatology (ESEGH) in 2016. Dr. Alboraie has been trained on basic and advanced endoscopy at Al-Azhar University in Cairo, Magdeburg University in Germany and in Haya Al-Habeeb Gastroenterology Center in Kuwait. He is currently working as a lecturer of hepatology, gastroenterology and endoscopy at Al-Azhar University in Cairo, is the Executive Director of Presidential initiative for treating one million African hepatitis C patients, secretary general of the Egyptian Association for Research and Training in Hepato-Gastroenterology (EARTH), executive secretary of Egyptian Society of Crohn’s and Colitis (ESCCO), Secretary General of the African Helicobacter and Microbiota Study Initiative (AHMSI) and is the representative of EARTH at United European Gastroenterology (UEG) meeting of members and national society forum. Dr. Alboraie is also a member in many international societies including World Endoscopy Organization (WEO), WEO emerging stars, American Gastroenterology Association (AGA), American College of Gastroenterology (ACG), European Association for the Study of the Liver (EASL), Asia Pacific Association for the Study of the Liver (APASL), European Crohn’s and Colitis Organization (ECCO) and is a founding member of European Society for Study of Coeliac Disease (ESSCD). Please find more information about Dr. Alboraie on Researchgate.

 

Positions

  • 2016-current: Consultant of internal medicine, gastroenterology and hepatology, (EMS), Egypt; demonstrator at the department of internal medicine, Al-Azhar University, Cairo, Egypt.
  • 2010-2016: Senior gastroenterologist and hepatologist at the Haya Al-Habeeb GIT Center, department of internal medicine, Mubarak Al-Kabeer Hospital, Kuwait. 
  • 2010: Gastroenterology and hepatology training at department of Gastroenterology, hepatology and infectious diseases (Prof. Peter Malfertheiner), Otto von Guericke University, Magdeburg, Germany.
  • 2007-2009: Specialist of internal medicine, gastroenterology, hepatology and endoscopy at Mouwasat hospital, Dammam, Saudi Arabia (www.mouwasat.com); age/gender screening program coordinator; joint commission international co-chapter leader for the ACC chapter.
  • 2007: Specialist of internal medicine and gastroenterology at Cairo Medical Center, Gastroenterology and hepatology clinic (Prof. Sherif Abdelfattah), Cairo, Egypt; specialist of internal medicine and gastroenterology at International Medical Center (www.imceg.com) Cairo, Egypt.
  • 2005-2006: Specialist of internal medicine and intermediate care unit at Abdel-Kadar Fahmy Hospital, Golf Land, Cairo, Egypt.
  • 2004-2007: Resident doctor at the department of internal medicine (gastroenterology, hepatology and endoscopy unit) at Al-Hussein Hospital, Al-Azhar University, Cairo, Egypt. 
  • 2003-2004: House officer, Al-Hussein hospital, faculty of medicine, Al-Azhar University, Cairo, Egypt.

 

Research interest

Dr. Alboraies’s main research interest include acid related disorders, Helicobacter pylori and microbiota, Inflammatory Bowel Disease, Irritable Bowel Syndrome, viral hepatitis (B and C), celiac disease, colon cancer, basic and advanced endoscopic procedures.

 

Task

Special Guest in the panel discussion

iGES is powered by Eucarbon®

Eucarbon, a herbal remedy to naturally regulate digestion and relieve constipation and flatulence.  

Regulative  I  Mildly laxative  I  Carminative

About Eucarbon